Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21 century.
作者信息
Weberpals Janick, Pulte Dianne, Jansen Lina, Luttmann Sabine, Holleczek Bernd, Nennecke Alice, Ressing Meike, Katalinic Alexander, Merz Maximilian, Brenner Hermann
机构信息
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
出版信息
Haematologica. 2017 Jun;102(6):e229-e232. doi: 10.3324/haematol.2016.157768. Epub 2017 Mar 9.
Abstract
摘要
相似文献
1
Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21 century.21世纪初德国和美利坚合众国淋巴浆细胞淋巴瘤及孤立性浆细胞瘤患者的生存率
Haematologica. 2017 Jun;102(6):e229-e232. doi: 10.3324/haematol.2016.157768. Epub 2017 Mar 9.
2
Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database.华氏巨球蛋白血症的生存趋势：监测、流行病学和最终结果数据库分析
Blood. 2014 Jun 19;123(25):3999-4000. doi: 10.1182/blood-2014-05-574871.
3
Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005.华氏巨球蛋白血症：一项对1988年至2005年监测、流行病学和最终结果数据库的回顾
Leuk Lymphoma. 2012 Aug;53(8):1625-6. doi: 10.3109/10428194.2012.656103. Epub 2012 Feb 13.
4
Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.华氏巨球蛋白血症/淋巴浆细胞淋巴瘤患者静脉血栓风险升高，但动脉血栓风险未升高。
J Thromb Haemost. 2014 Nov;12(11):1816-21. doi: 10.1111/jth.12724. Epub 2014 Oct 6.
5
Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.2000-2016 年淋巴浆细胞淋巴瘤/华氏巨球蛋白血症患者的病因特异性死亡率。
Br J Haematol. 2020 Jun;189(6):1107-1118. doi: 10.1111/bjh.16492. Epub 2020 Feb 23.
6
Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study.华氏巨球蛋白血症发病率的时间和地理变异：一项大型基于人群的研究。
Cancer. 2012 Aug 1;118(15):3793-800. doi: 10.1002/cncr.26627. Epub 2011 Dec 2.
7
Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United States.美国冒烟型华氏巨球蛋白血症的患病率及生存率
Br J Haematol. 2019 Mar;184(6):1014-1017. doi: 10.1111/bjh.15201. Epub 2018 Mar 13.
8
Second cancers in survivors of plasmacytoma of bone in the U.S.A: a SEER database analysis.美国骨浆细胞瘤幸存者的二次癌症：一项监测、流行病学和最终结果（SEER）数据库分析
Leuk Lymphoma. 2017 Dec;58(12):2952-2956. doi: 10.1080/10428194.2017.1312386. Epub 2017 Apr 12.
9
Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.美国浆细胞瘤的总生存趋势及临床特征：一项国家癌症数据库分析
Clin Lymphoma Myeloma Leuk. 2019 May;19(5):310-319. doi: 10.1016/j.clml.2019.01.004. Epub 2019 Jan 19.
10
Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.华氏巨球蛋白血症患者继发恶性肿瘤的发病率：对 SEER 数据库的分析。
Cancer. 2015 Jul 1;121(13):2230-6. doi: 10.1002/cncr.29334. Epub 2015 Mar 10.
引用本文的文献
1
Prediction of Solitary Plasmacytoma of Bone in Elderly Patients: A Nomogram and a Risk Classification System for Overall Survival.老年患者孤立性骨浆细胞瘤的预测：总生存的列线图和风险分类系统。
Biomed Res Int. 2022 Jun 1;2022:7387416. doi: 10.1155/2022/7387416. eCollection 2022.
2
Multiple myeloma with central nervous system relapse.多发性骨髓瘤伴中枢神经系统复发。
Haematologica. 2020 Jul;105(7):1780-1790. doi: 10.3324/haematol.2020.248518. Epub 2020 May 15.
3
Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset.浆细胞瘤的治疗方法和结果：利用国家数据集进行分析。
Leukemia. 2018 Jun;32(6):1414-1420. doi: 10.1038/s41375-018-0099-8. Epub 2018 Mar 21.
4
Solitary Plasmacytoma.孤立性浆细胞瘤
Mediterr J Hematol Infect Dis. 2017 Aug 23;9(1):e2017052. doi: 10.4084/MJHID.2017.052. eCollection 2017.
本文引用的文献
1
Changes in the survival of older patients with hematologic malignancies in the early 21st century.21世纪初老年血液系统恶性肿瘤患者生存率的变化。
Cancer. 2016 Jul 1;122(13):2031-40. doi: 10.1002/cncr.30003. Epub 2016 May 10.
2
Primary Plasma Cell Leukemia in the Era of Novel Agents: A Multicenter Study of the Japanese Society of Myeloma.新型药物时代的原发性浆细胞白血病：日本骨髓瘤学会的多中心研究
Acta Haematol. 2016;135(2):113-21. doi: 10.1159/000439424. Epub 2015 Oct 28.
3
Changes in survival rate of multiple myeloma after the introduction of bortezomib: a single institutional experience over 20 years.硼替佐米引入后多发性骨髓瘤生存率的变化：一项20多年的单机构经验
Ann Hematol. 2016 Jan;95(1):63-72. doi: 10.1007/s00277-015-2522-9.
4
Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century.21世纪头十年德国和美国多发性骨髓瘤患者的生存趋势。
Br J Haematol. 2015 Oct;171(2):189-196. doi: 10.1111/bjh.13537. Epub 2015 Jun 30.
5
Radiotherapy Alone is Associated with Improved Outcomes Over Surgery in the Management of Solitary Plasmacytoma.在孤立性浆细胞瘤的治疗中，单纯放疗与手术相比，预后更佳。
Asian Pac J Cancer Prev. 2015;16(9):3741-5. doi: 10.7314/apjcp.2015.16.9.3741.
6
Treatment options for relapsed and refractory multiple myeloma.复发和难治性多发性骨髓瘤的治疗选择。
Blood. 2015 May 14;125(20):3085-99. doi: 10.1182/blood-2014-11-568923. Epub 2015 Apr 2.
7
Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database.华氏巨球蛋白血症患者的总生存期和死亡的竞争风险：监测、流行病学和最终结果数据库分析
Br J Haematol. 2015 Apr;169(1):81-9. doi: 10.1111/bjh.13264. Epub 2014 Dec 18.
8
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.卡非佐米、来那度胺和地塞米松治疗复发多发性骨髓瘤。
N Engl J Med. 2015 Jan 8;372(2):142-52. doi: 10.1056/NEJMoa1411321. Epub 2014 Dec 6.
9
Recent cancer survival in Germany: an analysis of common and less common cancers.德国近期的癌症生存率：常见与罕见癌症分析
Int J Cancer. 2015 Jun 1;136(11):2649-58. doi: 10.1002/ijc.29316. Epub 2014 Nov 26.
10
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.欧洲 1997 年至 2008 年按地区和年龄划分的血液恶性肿瘤生存情况：基于人群的 EUROCARE-5 研究结果。
Lancet Oncol. 2014 Aug;15(9):931-42. doi: 10.1016/S1470-2045(14)70282-7. Epub 2014 Jul 13.
Zotero 插件